This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Batchelor, M.
Right arrow Articles by Liebana, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batchelor, M.
Right arrow Articles by Liebana, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2005, p. 2261-2265, Vol. 43, No. 5
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.5.2261-2265.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Characterization of AmpC-Mediated Resistance in Clinical Salmonella Isolates Recovered from Humans during the Period 1992 to 2003 in England and Wales

M. Batchelor,1 K. L. Hopkins,2 E. J. Threlfall,2 F. A. Clifton-Hadley,1 A. D. Stallwood,1 R. H. Davies,1 and E. Liebana1*

Department of Food and Environmental Safety, Veterinary Laboratories Agency, Addlestone, Surrey KT153NB,1 Laboratory for Enteric Pathogens, Health Protection Agency, London NW95HT, United Kingdom2

Received 28 October 2004/ Returned for modification 31 December 2004/ Accepted 23 January 2005

The increase in AmpC-mediated resistance in salmonellae constitutes a serious public health concern, since these enzymes confer resistance to a wide range of ß-lactams. One hundred six isolates were selected from 278,308 Salmonella isolates based on resistance to ampicillin and cephalosporins and were subjected to further characterization. Nine isolates had a cefoxitin inhibition diameter ≤17 mm and were proven to be AmpC positive by multiplex PCR. Sequence analysis revealed the presence of blaDHA-1, blaCMY-2, and blaCMY-4 genes. All nine isolates presented different pulsed-field gel electrophoresis restriction profiles. The AmpC genetic determinants were present in transferable plasmids of around 11, 42, 70, 98, and 99 MDa. A combination of size and restriction fragment length polymorphism (RFLP) analysis showed that all the blaCMY plasmids investigated in our study were different, which suggests that blaCMY may be located in different plasmid environments. Some United Kingdom isolates linked to foreign travel showed RFLP plasmid patterns consistent with plasmids previously seen in the United States, which suggests that blaCMY-2 has also been disseminated through plasmid transfer. The fact that two of the domestically acquired United Kingdom isolates presented previously unseen RFLP plasmid patterns could indicate that these strains have followed routes different from those prevalent in North America or other parts of the world. This study represents the first report of blaCMY genes in Salmonella isolates in the United Kingdom and the first report of CMY-4 in Salmonella enterica serotype Senftenberg worldwide.

* Corresponding author. Mailing address: Department of Food and Environmental Safety, Veterinary Laboratories Agency, Addlestone, Surrey KT153NB, United Kingdom. Phone: 44-1932359582. Fax: 44-1932357595. E-mail: E.Liebana{at}VLA.DEFRA.gsi.gov.UK.

Journal of Clinical Microbiology, May 2005, p. 2261-2265, Vol. 43, No. 5
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.5.2261-2265.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rodriguez, I., Barownick, W., Helmuth, R., Mendoza, M. C., Rodicio, M. R., Schroeter, A., Guerra, B. (2009). Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07. J Antimicrob Chemother 64: 301-309 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Woodford, N., Reddy, S., Fagan, E. J., Hill, R. L. R., Hopkins, K. L., Kaufmann, M. E., Kistler, J., Palepou, M.-F. I., Pike, R., Ward, M. E., Cheesbrough, J., Livermore, D. M. (2007). Wide geographic spread of diverse acquired AmpC {beta}-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 59: 102-105 [Abstract] [Full Text]  
  • Hopkins, K. L., Liebana, E., Villa, L., Batchelor, M., Threlfall, E. J., Carattoli, A. (2006). Replicon Typing of Plasmids Carrying CTX-M or CMY {beta}-Lactamases Circulating among Salmonella and Escherichia coli Isolates.. Antimicrob. Agents Chemother. 50: 3203-3206 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»